Activity 3 – Safe and Effective Pain Management Utilizing Opioid Therapy

Current Status
Not Enrolled
Get Started
Activity 3 Safe And Effective Pain Management Utilizing Opioid Therapy

Release date: 6/1/2023

Expiration date: 6/1/2024

Activity Overview
This accredited CE activity was designed to meet educational requirements as outlined in the Medication Access and Training Expansion (MATE) Act. Content areas discussed include strategies for assessing and managing pain in patients utilizing opioids. The signs and symptoms of opioid use disorder (OUD) also are discussed.

Target Audience
All Drug Enforcement Administration (DEA)-registered practitioners who treat patients with opioid or other substance use disorders, including physicians, nurse practitioners, physician assistants, and dentists.

Learning Objectives
Upon completion of the educational activity, participants should be able to:

  • Review the assessment and treatment of patients with acute, subacute, or chronic pain.
  • Develop effective treatment plans and interprofessional treatment interventions.
  • List current recommendations and strategies for the management of pain in patients utilizing opioid therapy.
  • Recognizing signs and symptoms of opioid use disorder (OUD).

Criteria for Success
To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. If you have questions about this activity, please contact AKH Inc. at [email protected].

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.

Ideal Pah Patient Care: New Treatments And Technology Can Improve Patient Outcomes

In support of improving patient care, AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

New Injector Immersion Didactic

This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Preventing Medical Errors

Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. Approval is valid until 6/1/2025. PAs should only claim credit commensurate with the extent of their participation.

Cmt Neurology For Clinicians

Nurse Practitioners
AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 2.0 contact hour(s) (which includes 0 hour(s) of pharmacology).

National Accreditations

AKH Inc., Advancing Knowledge in Healthcare is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at

AKH Inc., Advancing Knowledge in Healthcare designates this activity for 2.0 continuing education credits.

Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at

Commercial Support
There is no commercial support for this activity.

Margaret A. Clark, MSc, RN, RRT – NPS, CMPP

Planners and Reviewers
Dorothy Caputo, MA, BSN, RN, VP, Healthcare Continuing Education and Operations
Bernadette Makar, MSN, APRN-BC, NP-C

None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All of the relevant financial relationships listed for these individuals have been mitigated.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.